Exploiting nature's rich source of proteasome inhibitors as starting points in drug development

Melissa Ann Gräwert, Michael Groll
  • Chemical Communications, January 2012, Royal Society of Chemistry
  • DOI: 10.1039/c1cc15273d
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: